Bcl-2 intersects the NFκB signalling pathway and suppresses apoptosis in ventricular myocytes

Clinical and Investigative Medicine

Volumn 23, Issue 5, 2000, Pages 322-330

  Kirshenbaum, L A ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; HEART VENTRICLE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELLS, CULTURED; GENE EXPRESSION; HEART VENTRICLES; MYOCARDIUM; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033748413     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Apoptosis (the 1992 Frank Rose Memorial Lecture)
2. The genetic regulation of apoptosis
3. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview
4. Apoptosis: Mechanisms and roles in pathology
5. Apoptosis in the pathogenesis and treatment of disease
6. Cell death in cancer and development. AACR special conference in cancer research
7. Apoptosis and cancer: The failure of controls on cell death and cell survival
8. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
9. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes
10. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
11. Apoptosis in myocytes in endstage heart failure
12. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes
13. Apoptosis in human atherosclerosis and restenosis
14. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor
15. NF-kappa B: Ten years after
16. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
17. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB
18. A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene
19. The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences
20. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B
21. The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity
22. I kappa B: A specific inhibitor of the NF-kappa B transcription factor
23. The inhibitory ankyrin and activator Rel proteins
24. Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus
25. Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B
26. Tumor necrosis factor beta (TNF-beta) induces binding of the NF-kappa B transcription factor to a high-affinity kappa B element in the TNF-beta promoter
27. NF-kappa B: A pleiotropic mediator of inducible and tissue-specific gene control
28. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB
29. Signal-induced degradation of I(kappa)B(alpha): Association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required
30. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B
31. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B
32. NF-kappa B controls expression of inhibitor I kappa B alpha: Evidence for an inducible autoregulatory pathway
33. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways
34. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
35. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
36. The ins and outs of programmed cell death during C. elegans development
37. Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2
38. Programmed cell death in Caenorhabditis elegans
39. Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines
40. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
41. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins
42. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
43. Programmed cell death: Bcl-2
44. Mitochondria and apoptosis
45. Bcl-2 and the regulation of programmed cell death
46. Regulation of lymphocyte survival by the bcl-2 gene family
47. The Bcl-2 protein family: Arbiters of cell survival
48. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
49. Functional dissection of the human Bcl2 protein: Sequence requirements for inhibition of apoptosis
50. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax
51. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
52. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4
53. Evidence for alpha-helical conformation of an essential N-terminal region in the human Bcl2 protein
54. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
55. Bcl-x(L) forms an ion channel in synthetic lipid membranes
56. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
57. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release
58. Bcl-2 targets the protein kinase Raf-1 to mitochondria
59. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
60. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
61. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
62. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase
63. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD
64. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein-and p300-binding domains
65. Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis
66. p53-Independent apoptotic and necrotic cell deaths induced by adenovirus infection: Suppression by E1B 19K and Bcl-2 proteins
67. The bcl-2 gene product prevents programmed cell death of ventricular myocytes
68. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha